Total Payments
$2,847
2022 Payments
$1,186
Companies
6
Transactions
21
Medicare Patients
36,086
Medicare Billing
$15.2M
Payment Breakdown by Category
Travel$1,784 (62.7%)
Food & Beverage$1,052 (37.0%)
Gifts$11.00 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,784 | 7 | 62.7% |
| Food and Beverage | $1,052 | 13 | 37.0% |
| Gift | $11.00 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medline Industries LP | $2,258 | 14 | $0 (2022) |
| Cook Incorporated | $153.85 | 1 | $0 (2017) |
| Melinta Therapeutics, Inc. | $121.87 | 1 | $0 (2019) |
| Horizon Therapeutics plc | $114.99 | 1 | $0 (2021) |
| Cook Medical LLC | $110.51 | 3 | $0 (2020) |
| Cardiovascular Systems Inc. | $87.50 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $1,186 | 5 | Medline Industries LP ($1,186) |
| 2021 | $114.99 | 1 | Horizon Therapeutics plc ($114.99) |
| 2020 | $57.50 | 2 | Cook Medical LLC ($57.50) |
| 2019 | $1,104 | 9 | Medline Industries, Inc. ($982.45) |
| 2018 | $230.70 | 3 | Medline Industries, Inc. ($90.19) |
| 2017 | $153.85 | 1 | Cook Incorporated ($153.85) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/28/2022 | Medline Industries LP | — | Travel and Lodging | In-kind items and services | $723.25 | General |
| 04/28/2022 | Medline Industries LP | — | Travel and Lodging | In-kind items and services | $160.00 | General |
| 04/28/2022 | Medline Industries LP | — | Food and Beverage | In-kind items and services | $145.34 | General |
| 04/28/2022 | Medline Industries LP | — | Travel and Lodging | In-kind items and services | $145.00 | General |
| 04/28/2022 | Medline Industries LP | — | Food and Beverage | In-kind items and services | $12.11 | General |
| 10/19/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $114.99 | General |
| Category: KRYSTEXXA | ||||||
| 01/13/2020 | Cook Medical LLC | Cook Medical Zilver PTX (Device) | Food and Beverage | Cash or cash equivalent | $39.64 | General |
| Category: Peripheral Intervention | ||||||
| 01/07/2020 | Cook Medical LLC | Cook Medical Zilver PTX (Device) | Food and Beverage | Cash or cash equivalent | $17.86 | General |
| Category: Peripheral Intervention | ||||||
| 06/06/2019 | Medline Industries, Inc. | — | Gift | In-kind items and services | $11.00 | General |
| 06/06/2019 | Medline Industries, Inc. | — | Food and Beverage | In-kind items and services | $8.91 | General |
| 06/05/2019 | Medline Industries, Inc. | — | Food and Beverage | In-kind items and services | $124.48 | General |
| 06/05/2019 | Medline Industries, Inc. | — | Food and Beverage | In-kind items and services | $82.40 | General |
| 06/04/2019 | Medline Industries, Inc. | — | Travel and Lodging | In-kind items and services | $366.60 | General |
| 06/04/2019 | Medline Industries, Inc. | — | Travel and Lodging | In-kind items and services | $335.26 | General |
| 06/04/2019 | Medline Industries, Inc. | — | Travel and Lodging | In-kind items and services | $47.80 | General |
| 06/04/2019 | Medline Industries, Inc. | — | Travel and Lodging | In-kind items and services | $6.00 | General |
| 02/04/2019 | Melinta Therapeutics, Inc. | Orbactiv (Drug), Baxdela | Food and Beverage | In-kind items and services | $121.87 | General |
| Category: ANTIBIOTICS | ||||||
| 10/23/2018 | Cook Medical LLC | COOK MEDICAL ZILVER PTX (Device) | Food and Beverage | Cash or cash equivalent | $53.01 | General |
| Category: Peripheral Intervention | ||||||
| 10/22/2018 | Cardiovascular Systems Inc. | Peripheral Orbital Atherectomy System (Device) | Food and Beverage | Cash or cash equivalent | $87.50 | General |
| Category: Atherectomy Device | ||||||
| 08/23/2018 | Medline Industries, Inc. | — | Food and Beverage | In-kind items and services | $90.19 | General |
| 09/08/2017 | Cook Incorporated | Cook Medical Zilver PTX (Device) | Food and Beverage | Cash or cash equivalent | $153.85 | General |
| Category: Peripheral Intervention | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 4,667 | 15,391 | $1.1M | $557,657 |
| 2022 | 26 | 16,311 | 72,382 | $15.7M | $10.7M |
| 2021 | 19 | 7,715 | 22,121 | $5.0M | $3.4M |
| 2020 | 20 | 7,393 | 10,772 | $969,028 | $601,342 |
Total Patients
36,086
Total Services
120,666
Medicare Billing
$15.2M
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 817 | 8,210 | $492,600 | $282,325 | 57.3% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2023 | 817 | 4,105 | $246,300 | $141,163 | 57.3% |
| 11755 | Biopsy of fingernail or toenail | Office | 2023 | 410 | 412 | $90,640 | $40,429 | 44.6% |
| 87641 | Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | Office | 2023 | 817 | 821 | $49,260 | $28,234 | 57.3% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2023 | 564 | 582 | $96,045 | $22,073 | 23.0% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2023 | 486 | 492 | $44,280 | $13,901 | 31.4% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 284 | 297 | $44,550 | $13,101 | 29.4% |
| 99342 | Residence visit for new patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 169 | 169 | $23,660 | $7,900 | 33.4% |
| 99341 | Residence visit for new patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 86 | 86 | $8,600 | $2,630 | 30.6% |
| 11720 | Removal of fingernails or toenails, 1-5 nails | Office | 2023 | 108 | 108 | $7,020 | $2,368 | 33.7% |
| 99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 80 | 80 | $8,000 | $2,166 | 27.1% |
| 11057 | Removal of noncancer thickened skin growth, more than 4 growths | Office | 2023 | 29 | 29 | $5,220 | $1,365 | 26.2% |
| Q4253 | Zenith amniotic membrane, per square centimeter | Office | 2022 | 25 | 5,352 | $4.2M | $3.3M | 79.4% |
| Q4252 | Vendaje, per square centimeter | Office | 2022 | 51 | 4,065 | $3.9M | $3.1M | 79.7% |
| Q4217 | Woundfix, biowound, woundfix plus, biowound plus, woundfix xplus or biowound xplus, per square centimeter | Office | 2022 | 33 | 3,528 | $1.8M | $1.4M | 80.0% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2022 | 1,967 | 22,992 | $1.4M | $794,174 | 57.5% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2022 | 824 | 4,532 | $1.1M | $527,496 | 46.6% |
| 99348 | Established patient home visit, typically 25 minutes | Office | 2022 | 1,879 | 6,788 | $1.0M | $456,975 | 44.9% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2022 | 1,966 | 11,481 | $689,340 | $396,567 | 57.5% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2022 | 2,279 | 3,817 | $343,530 | $137,301 | 40.0% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2022 | 1,112 | 2,225 | $378,125 | $127,942 | 33.8% |
| 11755 | Biopsy of fingernail or toenail | Office | 2022 | 920 | 1,020 | $224,420 | $111,512 | 49.7% |
| 99342 | New patient home visit, typically 30 minutes | Office | 2022 | 1,670 | 1,670 | $233,810 | $91,796 | 39.3% |
| 87641 | Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | Office | 2022 | 1,971 | 2,305 | $138,300 | $79,622 | 57.6% |
| 11000 | Removal of inflamed or infected skin, up to 10% of body surface | Office | 2022 | 859 | 1,453 | $159,830 | $65,607 | 41.0% |
About Dr. Christopher Otiko, DPM
Dr. Christopher Otiko, DPM is a Podiatrist healthcare provider based in Reseda, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1346223997.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Otiko, DPM has received a total of $2,847 in payments from pharmaceutical and medical device companies, with $1,186 received in 2022. These payments were reported across 21 transactions from 6 companies. The most common payment nature is "Travel and Lodging" ($1,784).
As a Medicare-enrolled provider, Otiko has provided services to 36,086 Medicare beneficiaries, totaling 120,666 services with total Medicare billing of $15.2M. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Podiatrist
- Location Reseda, CA
- Active Since 11/28/2005
- Last Updated 09/10/2015
- Taxonomy Code 213E00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346223997
Products in Payments
- Cook Medical Zilver PTX (Device) $211.35
- Orbactiv (Drug) $121.87
- KRYSTEXXA (Biological) $114.99
- Peripheral Orbital Atherectomy System (Device) $87.50
- COOK MEDICAL ZILVER PTX (Device) $53.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.